Citation Impact

Citing Papers

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
2008 Standout
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
2010 StandoutScience
Sleep Drives Metabolite Clearance from the Adult Brain
2013 StandoutScience
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
1998 StandoutNature
DNA Polymorphisms in Two Paraoxonase Genes (PON1 and PON2) Are Associated with the Risk of Coronary Heart Disease
1998
Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation
2000
Functions of DNA methylation: islands, start sites, gene bodies and beyond
2012 Standout
White collar 2,a partner in blue-light signal transduction, controlling expression of light-regulated genes in Neurospora crassa
1997
V-src-induced-transcription of the avian clusterin gene
1992
Cerebrovascular transport of Alzheimer's amyloidβ and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier
1996
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
DNA methylation patterns and epigenetic memory
2002 Standout
Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein
1997
Lipoproteomics I: Mapping of proteins in low‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry
2005
Structure of the Replicating Complex of a Pol α Family DNA Polymerase
2001 StandoutNobel
Clusterin is a secreted mammalian chaperone
2000
A Mutant Drosophila Homolog of Mammalian Clock Disrupts Circadian Rhythms and Transcription of period and timeless
1998 StandoutNobel
Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins
1999 Standout
The role of clusterin in tissue injury
1994
Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors
1997 StandoutNobel
Cancer stem cells revisited
2017 Standout
ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition
2004
The mechanosensory protein MEC-6 is a subunit of the C. elegans touch-cell degenerin channel
2002 StandoutNatureNobel
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Protein folding and misfolding
2003 StandoutNature
Identification of Glycoprotein 330 as an Endocytic Receptor for Apolipoprotein J/Clusterin
1995
Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states
1998
Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response
1998
Age-related macular degeneration
2018 Standout
Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells.
1995
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins
2009
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
1993
DNA methylation inhibits elongation but not initiation of transcription in Neurospora crassa
1997
Regulation of myocardial βARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing α1B-adrenergic receptors
2001 StandoutNobel
Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor Kinase
1997
Clusterin: the intriguing guises of a widely expressed glycoprotein
1992
Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death.
1994
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Next Generation Sequencing Analysis of Human Platelet PolyA+ mRNAs and rRNA-Depleted Total RNA
2013 StandoutNobel
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
1997
Atherosclerosis
2000 StandoutNature
Identification of a distinct human high‐density lipoprotein subspecies defined by a lipoprotein‐associated protein, K‐45
1993
Short TpA-rich segments of the ζ-η region induce DNA methylation in Neurospora crassa 1 1Edited by K. Yamamoto
2000
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Atherosclerosis
2001 Standout
Identification and characterization of glycosylation sites in human serum clusterin
1997
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
1997
Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
1999
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Molecular Mechanisms of Amyloidosis
2003 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry
2005
The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese
1998
Transcript profiling of human platelets using microarray and serial analysis of gene expression
2003
Expression of Clusterin/Sulfated Glycoprotein‐2 Under Conditions of Heat Stress in Rat Sertoli Cells and a Mouse Sertoli Cell Line
1997
Selective Plasma Hydrolysis of Glucocorticoid γ-Lactones and Cyclic Carbonates by the Enzyme Paraoxonase: An Ideal Plasma Inactivation Mechanism
1999
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
1997 Standout
In Vivo Ventricular Gene Delivery of a β-Adrenergic Receptor Kinase Inhibitor to the Failing Heart Reverses Cardiac Dysfunction
2001 StandoutNobel
Tc4, a Caenorhabditis elegans transposable element with an unusual fold-back structure.
1991 StandoutNobel
Genetic Polymorphism of Paraoxonase and the Risk of Coronary Heart Disease
1997
Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System
2006
Effect of Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial Hypercholesterolemic Patients
2000
Clusterin/ApoJ expression is associated with neuronal apoptosis in the olfactory mucosa of the adult mouse
1997
Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates
1996
Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?
1998
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
1998 Standout
Transforming Growth Factor β (TGFβ)-Induced Nuclear Localization of Apolipoprotein J/Clusterin in Epithelial Cells
1996
Clusterin
1993
Molecular coevolution within a Drosophila clock gene
1998 StandoutNobel
DNA Mismatch Repair:  Functions and Mechanisms
2005 StandoutNobel
Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease
2002
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
2013
In situ hybridization of DNA sequences in human metaphase chromosomes visualized by an indirect fluorescent immunocytochemical procedure
1982
Paraoxonase and Atherosclerosis
2001 Standout
Alzheimer's Disease: Genes, Proteins, and Therapy
2001 Standout
Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial Hypertrophy
1998 StandoutScienceNobel
The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
1993
Defective forebrain development in mice lacking gp330/megalin.
1996 Standout
Potential role of apolipoprotein-E in fibrillogenesis.
1994
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
2008 Standout
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Short-Term Feeding of Atherogenic Diet to Mice Results in Reduction of HDL and Paraoxonase That May Be Mediated by an Immune Mechanism
2000
Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.
1986 Standout
The Role of DNA Methylation in Mammalian Epigenetics
2001 StandoutScience
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Myc-Transformed Epithelial Cells Down-Regulate Clusterin, Which Inhibits Their Growth in Vitro and Carcinogenesis in Vivo
2004
Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
1996
Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma
1991
Increased Immunolocalization of Paraoxonase, Clusterin, and Apolipoprotein A-I in the Human Artery Wall With the Progression of Atherosclerosis
1997
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
A constant rate of spontaneous mutation in DNA-based microbes.
1991
Apolipoprotein J and Alzheimer's amyloid β solubility
1996
In Vivo Inhibition of Elevated Myocardial β-Adrenergic Receptor Kinase Activity in Hybrid Transgenic Mice Restores Normal β-Adrenergic Signaling and Function
1999 StandoutNobel
Unusual structure of the FB family of transposable elements in Drosophila
1981
Decrease of serum paraoxonase activity in chronic renal failure.
1998
Hybrid Transgenic Mice Reveal In Vivo Specificity of G Protein–Coupled Receptor Kinases in the Heart
2000 StandoutNobel
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Level of β-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure
2005 StandoutNobel

Works of William D. Stuart being referenced

Structure and stability of apolipoprotein J-containing high-density lipoproteins
1992
Apolipoprotein J Is Associated with Paraoxonase in Human Plasma
1994
Cloning of mtr, an amino acid transport gene of Neurospora crassa
1988
Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis
2000
Sequence and structure of mtr, an amino acid transport gene of Neurospora crassa
1991
Wnt/β-catenin signaling is required for development of the exocrine pancreas
2007
Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions.
1993
Apolipoprotein J/clusterin induction in myocarditis: A localized response gene to myocardial injury.
1996
A chimeric light-regulated amino acid transport system allows the isolation of blue light regulator (blr) mutants of Neurospora crassa.
1995
Purification and characterization of apolipoprotein J.
1990
A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins.
1990
An improved in situ hybridization method
1978
Rankless by CCL
2026